SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-014862
Filing Date
2023-06-08
Accepted
2023-06-08 16:15:37
Documents
2
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3987
2 EX-24 DOCUMENT attachment1.htm EX-24 4415
  Complete submission text file 0000899243-23-014862.txt   9812
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCPHARMACUETICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address
Baylor-Henry Minnie (Reporting) CIK: 0001747260 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 231002099